A Review: Drugs on Hypertension

Hypertension it is linked to renal problems, stroke, and cardiovascular illnesses, hypertension—also referred to as high blood pressure—is a serious worldwide health concern. It is typified by consistently high arterial pressure, which is frequently brought on by lifestyle, environmental, and hereditary factors. Pharmacological and non-pharmacological methods are the mainstays of hypertension treatment. Depending on the demands of each patient, a variety of antihypertensive medication classes are frequently administered, such as diuretics, beta-blockers, calcium channel blockers, angiotensin-converting enzyme (ACE) inhibitors, and angiotensin II receptor blockers (ARBs). Novel therapeutic drugs including vasodilators and direct renin inhibitors have been investigated recently to enhance blood pressure management and lessen side effects. Combination treatments are also frequently used in order to maximize effectiveness and reduce medication resistance. Poor drug adherence is still a significant problem, even with the abundance of treatment alternatives available. This can result in uncontrolled hypertension and increased morbidity. Additionally, developments in personalized therapy and precision medicine have the potential to improve the management of hypertension. The pharmacological treatments for hypertension are thoroughly examined in this review, with a focus on their mechanisms of action, clinical effectiveness, and possible adverse effects. Healthcare providers may choose the best treatment plans for better patient outcomes and efficient blood pressure control by having a thorough understanding of the therapeutic landscape of antihypertensive medications

Authors

Publication Details

Journal
International Journal for Research in Applied Science and Engineering Technology
Published
2025-04-11
DOI
https://doi.org/10.22214/ijraset.2025.68504
Primary Topic
Pharmaceutical Economics and Policy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Review: Drugs on Hypertension

Mallikarjun Patil
International Journal for Research in Applied Science and Engineering Technology
Pharmaceutical Economics and Policy
article

A Review: Drugs on Hypertension

Mallikarjun Patil
article en

Abstract

Hypertension it is linked to renal problems, stroke, and cardiovascular illnesses, hypertension—also referred to as high blood pressure—is a serious worldwide health concern. It is typified by consistently high arterial pressure, which is frequently brought on by lifestyle, environmental, and hereditary factors. Pharmacological and non-pharmacological methods are the mainstays of hypertension treatment. Depending on the demands of each patient, a variety of antihypertensive medication classes are frequently administered, such as diuretics, beta-blockers, calcium channel blockers, angiotensin-converting enzyme (ACE) inhibitors, and angiotensin II receptor blockers (ARBs). Novel therapeutic drugs including vasodilators and direct renin inhibitors have been investigated recently to enhance blood pressure management and lessen side effects. Combination treatments are also frequently used in order to maximize effectiveness and reduce medication resistance. Poor drug adherence is still a significant problem, even with the abundance of treatment alternatives available. This can result in uncontrolled hypertension and increased morbidity. Additionally, developments in personalized therapy and precision medicine have the potential to improve the management of hypertension. The pharmacological treatments for hypertension are thoroughly examined in this review, with a focus on their mechanisms of action, clinical effectiveness, and possible adverse effects. Healthcare providers may choose the best treatment plans for better patient outcomes and efficient blood pressure control by having a thorough understanding of the therapeutic landscape of antihypertensive medications

International Journal for Research in Applied Science and Engineering TechnologyVol. 13(4)
Openalex Percentile: Top 89%
Pharmaceutical Economics and Policy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.